KR20230005989A - 지질 나노 입자를 함유하는 입자 및 그 제조 방법 - Google Patents

지질 나노 입자를 함유하는 입자 및 그 제조 방법 Download PDF

Info

Publication number
KR20230005989A
KR20230005989A KR1020227042357A KR20227042357A KR20230005989A KR 20230005989 A KR20230005989 A KR 20230005989A KR 1020227042357 A KR1020227042357 A KR 1020227042357A KR 20227042357 A KR20227042357 A KR 20227042357A KR 20230005989 A KR20230005989 A KR 20230005989A
Authority
KR
South Korea
Prior art keywords
particles
liquid
lipid nanoparticles
particle
physiologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020227042357A
Other languages
English (en)
Korean (ko)
Inventor
다츠루 모리타니
사토미 오노우에
히데유키 사토
Original Assignee
가부시키가이샤 리코
시즈오카켄 코우리츠다이가쿠호진
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가부시키가이샤 리코, 시즈오카켄 코우리츠다이가쿠호진 filed Critical 가부시키가이샤 리코
Publication of KR20230005989A publication Critical patent/KR20230005989A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
KR1020227042357A 2020-05-20 2021-05-18 지질 나노 입자를 함유하는 입자 및 그 제조 방법 Ceased KR20230005989A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020088154 2020-05-20
JPJP-P-2020-088154 2020-05-20
PCT/JP2021/018751 WO2021235425A1 (ja) 2020-05-20 2021-05-18 脂質ナノ粒子を含有する粒子及びその製造方法

Publications (1)

Publication Number Publication Date
KR20230005989A true KR20230005989A (ko) 2023-01-10

Family

ID=78708467

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227042357A Ceased KR20230005989A (ko) 2020-05-20 2021-05-18 지질 나노 입자를 함유하는 입자 및 그 제조 방법

Country Status (7)

Country Link
US (1) US12508223B2 (https=)
EP (1) EP4169509A4 (https=)
JP (1) JPWO2021235425A1 (https=)
KR (1) KR20230005989A (https=)
CN (1) CN115666535B (https=)
CA (1) CA3183691A1 (https=)
WO (1) WO2021235425A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023178334A1 (en) * 2022-03-18 2023-09-21 Genentech, Inc. Nano-suspensions and amorophous solid dispersions of hydrophobic agents and methods of use thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5932993B2 (ja) 1979-06-25 1984-08-13 株式会社明電舎 多相インバ−タの電圧制御装置
JPH08133986A (ja) 1994-11-02 1996-05-28 Mitsubishi Chem Corp リポソーム凍結乾燥製剤
JP4228230B2 (ja) 2004-11-08 2009-02-25 独立行政法人産業技術総合研究所 リポソーム懸濁液の製造方法及びリポソームを用いた用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK288117B6 (sk) * 1998-11-20 2013-09-03 Skyepharma Canada Inc. Rapidly dispersing solid dry therapeutic dosage form
EP1458361A4 (en) 2001-11-20 2007-04-25 Advanced Inhalation Res Inc COMPOSITIONS FOR DISTRIBUTING PRODUCTS WITH LASTING EFFECT
JP4647506B2 (ja) 2006-01-27 2011-03-09 株式会社リコー 粒子特にトナー粒子の製造方法、トナー粒子の製造装置及びトナー
JP5055154B2 (ja) 2007-03-20 2012-10-24 株式会社リコー トナーの製造方法、トナーの製造装置及びトナー
US10973763B2 (en) 2011-06-17 2021-04-13 Berg Llc Inhalable pharmaceutical compositions
JP6953414B2 (ja) 2016-01-20 2021-10-27 フラリー パウダーズ エルエルシーＦｌｕｒｒｙ Ｐｏｗｄｅｒｓ，Ｌｌｃ 親油性成分を含む吸入に好適な分散性の噴霧乾燥粉末を製造する方法
JP6971043B2 (ja) 2016-03-04 2021-11-24 株式会社リコー 微粒子の製造方法
JP7105179B2 (ja) 2018-11-26 2022-07-22 株式会社トーキン 基板
JP7546344B2 (ja) 2018-02-09 2024-09-06 株式会社リコー 粒子の製造方法、粒子の製造装置、及び粒子
CN110123634A (zh) 2018-02-09 2019-08-16 株式会社理光 颗粒的制造方法，颗粒的制造装置，以及颗粒
JP7092974B2 (ja) 2018-03-26 2022-06-29 株式会社リコー 樹脂微粒子の製造方法、及び樹脂微粒子の製造装置
JP7192232B2 (ja) 2018-03-30 2022-12-20 株式会社リコー 医薬品用粒子の製造装置、及び医薬品用粒子の製造方法
EP3829644A4 (en) * 2018-07-30 2022-05-04 Ricoh Company, Ltd. PROCESS FOR MANUFACTURING PARTICLES AND PARTICLE AND MEDICATION MANUFACTURED BY THE PROCESS
JP7503781B2 (ja) * 2018-07-30 2024-06-21 株式会社リコー 粒子の製造方法、並びに、それにより製造された粒子及び医薬
JP2020152674A (ja) 2019-03-20 2020-09-24 株式会社リコー 難水溶性化合物の可溶化物の製造方法
WO2020261619A1 (ja) 2019-06-26 2020-12-30 株式会社リコー 医薬組成物
EP3989940A1 (en) 2019-06-26 2022-05-04 Ricoh Company, Ltd. Instantly soluble particle and method for producing the same
JP2021028305A (ja) 2019-08-09 2021-02-25 株式会社リコー 粒子、医薬組成物、及び粒子の製造方法
JP7600528B2 (ja) 2020-03-16 2024-12-17 株式会社リコー 粒子の製造方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5932993B2 (ja) 1979-06-25 1984-08-13 株式会社明電舎 多相インバ−タの電圧制御装置
JPH08133986A (ja) 1994-11-02 1996-05-28 Mitsubishi Chem Corp リポソーム凍結乾燥製剤
JP4228230B2 (ja) 2004-11-08 2009-02-25 独立行政法人産業技術総合研究所 リポソーム懸濁液の製造方法及びリポソームを用いた用途

Also Published As

Publication number Publication date
US20230210767A1 (en) 2023-07-06
CN115666535B (zh) 2024-06-18
EP4169509A4 (en) 2024-06-05
CA3183691A1 (en) 2021-11-25
EP4169509A1 (en) 2023-04-26
CN115666535A (zh) 2023-01-31
WO2021235425A1 (ja) 2021-11-25
JPWO2021235425A1 (https=) 2021-11-25
US12508223B2 (en) 2025-12-30

Similar Documents

Publication Publication Date Title
JP7600528B2 (ja) 粒子の製造方法
EP3423039B1 (en) Method for producing particles
EP3881831A1 (en) Sustained-release particles and production method thereof
EP3524233B1 (en) Particle-producing method and particle-producing apparatus
EP4335435A1 (en) Sustained releasing particle and method of producing sustained releasing particle
KR102755855B1 (ko) 입자의 제조 방법, 및 이 방법에 의해 제조된 입자 및 의약
JP7546344B2 (ja) 粒子の製造方法、粒子の製造装置、及び粒子
US20220273575A1 (en) Particles, pharmaceutical composition, and method for producing particles
JP7503781B2 (ja) 粒子の製造方法、並びに、それにより製造された粒子及び医薬
US12508223B2 (en) Particle containing lipid nanoparticles and method for producing same
EP4725477A1 (en) Particles, method for producing particles, and pharmaceutical composition
JP2026055749A (ja) 粒子及びその製造方法、並びに医薬組成物
JP2024039591A (ja) 徐放性粒子及びその製造方法
US20230182097A1 (en) Particle production apparatus and particle production method

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

B15 Application refused following examination

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B15-EXM-PE0601 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601